What is the clinical impact of the LUX-Lung 5 trial?
Ann Oncol
.
2016 Jun;27(6):1171-1172.
doi: 10.1093/annonc/mdw102.
Epub 2016 Mar 2.
Author
A Addeo
1
Affiliation
1
Department of Oncology, Bristol Cancer Centre, Bristol, UK. Electronic address:
[email protected]
.
PMID:
26940690
DOI:
10.1093/annonc/mdw102
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung*
Humans
Lung Neoplasms
Quinazolines*
Substances
Quinazolines